The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval for a version of Zepbound this year.

Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, compounded GLP-1s, and oral weight loss medications, like

Weight loss while taking Zepbound varies depending on individual factors, including response to the drug, initial body weight, lifestyle habits, and dosage. Clinical trials have shown that people taking tirzepatide can lose more than 10% of their body ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class I obesity. Researchers evaluated whether early ...

The first GLP-1 oral pill is now available at pharmacies nationwide. The Wegovy pill was approved by the Food and Drug Administration on December 22. Having an oral version of the medication, which had only been available as an injectable until now,